1. Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, Cox J, Ghali WA, Grace S, Hamet P, Ho T, Kirkland S, Lambert M, Libersan D, O’Loughlin J, Paradis G, Petrovich M, Tagalakis V (2007) A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 176:1–44. doi:
10.1503/cmaj.051455
2. World Health Organization (2006) Changes in death rates from CHD, men and women aged 35–74, between 1990 and 2000, selected countries. [Web site of the British Heart Foundation].
www.heartstats.org/temp/Figsp1.5bspweb06.xls
3. Yeghiazaryan K, Bauriedel G, Schild HH, Golubnitschaja O (2008) Prediction of degeneration of native and bioprosthetic aortic valves: issue-related particularities of Diabetes mellitus. Infect Disord Drug Targets 8:88–99
4. Yeghiazaryan K, Skowasch D, Bauriedel G, Schild HH, Golubnitschaja O (2009) Prediction of degeneration of native and bioprosthetic aortic valves. In: Golubnitschaja O (ed) Predictive diagnostics and personalized treatment: dream or reality. Nova Science Publishers Inc., New York
5. Yeghiazaryan K, Skowasch D, Bauriedel G, Schild H, Golubnitschaja O (2011) Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments. EPMA J 2(1):91–105. doi:
10.1007/s13167-011-0072-3